Logo image of IRES.I

IRISH RESIDENTIAL PROPERTIES (IRES.I) Stock Fundamental Analysis

DUB:IRES - Euronext Dublin - IE00BJ34P519 - REIT - Currency: EUR

1.086  +0.01 (+0.74%)

Fundamental Rating

2

IRES gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 5 industry peers in the Residential REITs industry. Both the profitability and financial health of IRES have multiple concerns. IRES is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

IRES had negative earnings in the past year.
IRES had a positive operating cash flow in the past year.
In multiple years IRES reported negative net income over the last 5 years.
In the past 5 years IRES always reported a positive cash flow from operatings.
IRES.I Yearly Net Income VS EBIT VS OCF VS FCFIRES.I Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.53%, IRES is doing worse than 80.00% of the companies in the same industry.
With a Return On Equity value of -1.00%, IRES is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
Looking at the Return On Invested Capital, with a value of 3.73%, IRES is in line with its industry, outperforming 60.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for IRES is in line with the industry average of 3.37%.
The 3 year average ROIC (3.55%) for IRES is below the current ROIC(3.73%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.53%
ROE -1%
ROIC 3.73%
ROA(3y)-3.41%
ROA(5y)-0.34%
ROE(3y)-6.34%
ROE(5y)-0.89%
ROIC(3y)3.55%
ROIC(5y)3.34%
IRES.I Yearly ROA, ROE, ROICIRES.I Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

IRES's Operating Margin of 61.71% is in line compared to the rest of the industry. IRES outperforms 60.00% of its industry peers.
IRES's Operating Margin has declined in the last couple of years.
IRES has a Gross Margin (78.06%) which is in line with its industry peers.
In the last couple of years the Gross Margin of IRES has remained more or less at the same level.
Industry RankSector Rank
OM 61.71%
PM (TTM) N/A
GM 78.06%
OM growth 3Y-1.31%
OM growth 5Y-1.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.79%
GM growth 5Y-1.09%
IRES.I Yearly Profit, Operating, Gross MarginsIRES.I Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200

More info and screens

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IRES is destroying value.
The number of shares outstanding for IRES remains at a similar level compared to 1 year ago.
IRES has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, IRES has a worse debt to assets ratio.
IRES.I Yearly Shares OutstandingIRES.I Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
IRES.I Yearly Total Debt VS Total AssetsIRES.I Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of 0.90, we must say that IRES is in the distress zone and has some risk of bankruptcy.
IRES's Altman-Z score of 0.90 is amongst the best of the industry. IRES outperforms 100.00% of its industry peers.
The Debt to FCF ratio of IRES is 11.16, which is on the high side as it means it would take IRES, 11.16 years of fcf income to pay off all of its debts.
IRES has a Debt to FCF ratio of 11.16. This is comparable to the rest of the industry: IRES outperforms 60.00% of its industry peers.
A Debt/Equity ratio of 0.85 indicates that IRES is somewhat dependend on debt financing.
IRES has a Debt to Equity ratio of 0.85. This is comparable to the rest of the industry: IRES outperforms 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 11.16
Altman-Z 0.9
ROIC/WACC0.67
WACC5.54%
IRES.I Yearly LT Debt VS Equity VS FCFIRES.I Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

IRES has a Current Ratio of 0.76. This is a bad value and indicates that IRES is not financially healthy enough and could expect problems in meeting its short term obligations.
IRES has a Current ratio of 0.76. This is in the better half of the industry: IRES outperforms 80.00% of its industry peers.
IRES has a Quick Ratio of 0.76. This is a bad value and indicates that IRES is not financially healthy enough and could expect problems in meeting its short term obligations.
IRES has a Quick ratio of 0.76. This is in the better half of the industry: IRES outperforms 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.76
IRES.I Yearly Current Assets VS Current LiabilitesIRES.I Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 94.25% over the past year.
The Revenue has decreased by -2.94% in the past year.
Measured over the past years, IRES shows a small growth in Revenue. The Revenue has been growing by 6.55% on average per year.
EPS 1Y (TTM)94.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%118.96%
Revenue 1Y (TTM)-2.94%
Revenue growth 3Y2.26%
Revenue growth 5Y6.55%
Sales Q2Q%-2.55%

3.2 Future

The Earnings Per Share is expected to grow by 2.78% on average over the next years.
Based on estimates for the next years, IRES will show a decrease in Revenue. The Revenue will decrease by 0.00% on average per year.
EPS Next Y4.76%
EPS Next 2Y6.9%
EPS Next 3Y2.78%
EPS Next 5YN/A
Revenue Next Year-2.3%
Revenue Next 2Y0%
Revenue Next 3Y0%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
IRES.I Yearly Revenue VS EstimatesIRES.I Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M
IRES.I Yearly EPS VS EstimatesIRES.I Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.02 0.04 0.06 0.08

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

IRES reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 19.36, the valuation of IRES can be described as rather expensive.
IRES's Price/Forward Earnings ratio is rather expensive when compared to the industry. IRES is more expensive than 80.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.17, IRES is valued at the same level.
Industry RankSector Rank
PE N/A
Fwd PE 19.36
IRES.I Price Earnings VS Forward Price EarningsIRES.I Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IRES indicates a slightly more expensive valuation: IRES is more expensive than 60.00% of the companies listed in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as IRES.
Industry RankSector Rank
P/FCF 11.23
EV/EBITDA 21.13
IRES.I Per share dataIRES.I EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.9%
EPS Next 3Y2.78%

More info and screens

4

5. Dividend

5.1 Amount

IRES has a Yearly Dividend Yield of 5.36%, which is a nice return.
IRES's Dividend Yield is comparable with the industry average which is at 5.53.
IRES's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 5.36%

5.2 History

The dividend of IRES decreases each year by -7.31%.
Dividend Growth(5Y)-7.31%
Div Incr Years0
Div Non Decr Years0
IRES.I Yearly Dividends per shareIRES.I Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.01 0.02 0.03 0.04 0.05

5.3 Sustainability

IRES has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-307.79%
EPS Next 2Y6.9%
EPS Next 3Y2.78%
IRES.I Yearly Income VS Free CF VS DividendIRES.I Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

More info and screens

IRISH RESIDENTIAL PROPERTIES

DUB:IRES (6/3/2025, 11:18:32 AM)

1.086

+0.01 (+0.74%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryResidential REITs
Earnings (Last)02-20 2025-02-20/amc
Earnings (Next)08-06 2025-08-06
Inst Owners75.55%
Inst Owner ChangeN/A
Ins Owners0.33%
Ins Owner ChangeN/A
Market Cap569.54M
Analysts80
Price Target0.97 (-10.68%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.36%
Yearly Dividend0.04
Dividend Growth(5Y)-7.31%
DP-307.79%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)5.56%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-5.98%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.41%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 19.36
P/S 6.68
P/FCF 11.23
P/OCF 11.22
P/B 0.85
P/tB 0.85
EV/EBITDA 21.13
EPS(TTM)-0.01
EYN/A
EPS(NY)0.06
Fwd EY5.17%
FCF(TTM)0.1
FCFY8.9%
OCF(TTM)0.1
OCFY8.91%
SpS0.16
BVpS1.27
TBVpS1.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.53%
ROE -1%
ROCE 4.26%
ROIC 3.73%
ROICexc 3.75%
ROICexgc 3.75%
OM 61.71%
PM (TTM) N/A
GM 78.06%
FCFM 59.47%
ROA(3y)-3.41%
ROA(5y)-0.34%
ROE(3y)-6.34%
ROE(5y)-0.89%
ROIC(3y)3.55%
ROIC(5y)3.34%
ROICexc(3y)3.57%
ROICexc(5y)3.36%
ROICexgc(3y)3.57%
ROICexgc(5y)3.36%
ROCE(3y)4.06%
ROCE(5y)3.82%
ROICexcg growth 3Y7.78%
ROICexcg growth 5Y6.87%
ROICexc growth 3Y7.78%
ROICexc growth 5Y6.87%
OM growth 3Y-1.31%
OM growth 5Y-1.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.79%
GM growth 5Y-1.09%
F-Score5
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 11.16
Debt/EBITDA 10.63
Cap/Depr 6.09%
Cap/Sales 0.04%
Interest Coverage 2.36
Cash Conversion 95.37%
Profit Quality N/A
Current Ratio 0.76
Quick Ratio 0.76
Altman-Z 0.9
F-Score5
WACC5.54%
ROIC/WACC0.67
Cap/Depr(3y)6.38%
Cap/Depr(5y)10.26%
Cap/Sales(3y)0.04%
Cap/Sales(5y)0.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)94.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%118.96%
EPS Next Y4.76%
EPS Next 2Y6.9%
EPS Next 3Y2.78%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.94%
Revenue growth 3Y2.26%
Revenue growth 5Y6.55%
Sales Q2Q%-2.55%
Revenue Next Year-2.3%
Revenue Next 2Y0%
Revenue Next 3Y0%
Revenue Next 5YN/A
EBIT growth 1Y-5.14%
EBIT growth 3Y0.92%
EBIT growth 5Y4.63%
EBIT Next Year-22.93%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-11.03%
FCF growth 3Y-1.51%
FCF growth 5Y2.93%
OCF growth 1Y-11%
OCF growth 3Y-1.49%
OCF growth 5Y2.94%